{
    "clinical_study": {
        "@rank": "165000", 
        "acronym": "LCD", 
        "arm_group": [
            {
                "arm_group_label": "2-week LCD", 
                "arm_group_type": "Active Comparator", 
                "description": "A 2-week liquid formula low-calorie diet (LCD) will be administered for 2 weeks prior to Roux-en-Y gastric bypass. The diet will provide 800kcal per day in the form of powdered milkshakes and soups"
            }, 
            {
                "arm_group_label": "6-week LCD", 
                "arm_group_type": "Active Comparator", 
                "description": "A 6-week liquid formula low-calorie diet (LCD) will be administered for 6 weeks prior to Roux-en-Y gastric bypass. The diet will provide 800kcal per day in the form of powdered milkshakes and soups"
            }, 
            {
                "arm_group_label": "Control diet", 
                "arm_group_type": "Active Comparator", 
                "description": "A conventional food diet will be followed for 2 weeks prior to Roux-en-Y gastric bypass. The diet, prescribed as a standard of care at Imperial Weight Centre by the bariatric dietitian will provided 800-1000kcal/day."
            }
        ], 
        "brief_summary": {
            "textblock": "Losing weight before undergoing Roux-en-Y gastric bypass (RYGB) surgery may reduce liver fat\n      content and size thereby improving surgical outcomes. This study aims to investigate whether\n      a 2-week or 6-week pre-operative liquid formula low-calorie diet (LCD) reduces liver fat\n      further than a conventional food diet prior to RYGB using magnetic resonance imaging (MRI).\n      The hypothesis is that the 2-week and 6-week liquid formula LCD will reduce liver fat\n      further than the conventional food pre-operative diet."
        }, 
        "brief_title": "Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Morbid Obesity", 
            "Liver Fat"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Obesity, Morbid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients undergoing Roux-en-Y gastric bypass at Imperial Weight Centre\n\n          -  aged 18 to 60 years\n\n          -  boby mass index of 35 to 55 kg/m2\n\n        Exclusion Criteria:\n\n          -  Claustrophobia\n\n          -  Pacemaker, metal implant, clips, implanted device, shrapnel or bullets, metal in eyes\n             that precludes magnetic resonance imaging\n\n          -  Current pregnancy or breast feeding for females (as determined by a pregnancy test)\n\n          -  A full term pregnancy within the last year for females\n\n          -  Treatment with any medication that might affect the study outcomes\n\n          -  Haemorrhagic disorders and anticoagulant treatment\n\n          -  History of cancer, excluding skin cancer\n\n          -  History of severe or multiple allergies, severe adverse drug reaction or leucopenia\n\n          -  Smokers\n\n          -  Regular drinkers of more than three units of alcohol daily\n\n          -  History of, or current evidence of, abuse of alcohol or any drug substance, licit or\n             illicit\n\n          -  Regular intake of over-the-counter (OTC) medication (other than the occasional\n             paracetamol/aspirin)\n\n          -  Poor compliers or subjects unlikely to commit to the 26 week study duration\n\n          -  Blood donation within the 12 week period before the initial study dose\n\n          -  Use of monoamine oxidase inhibitors (MAOIs) as anti depressant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02144597", 
            "org_study_id": "CRO1668"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "2-week LCD", 
                    "6-week LCD"
                ], 
                "description": "The liquid formula low-calorie diet (LCD) will provide 800kcal/day from powdered milkshakes and soups. The diet will be provided by Cambridge Weight Plan.", 
                "intervention_name": "Liquid formula low-calorie diet (LCD)", 
                "intervention_type": "Dietary Supplement", 
                "other_name": [
                    "LCD", 
                    "LED", 
                    "Cambridge Weight Plan"
                ]
            }, 
            {
                "arm_group_label": "Control diet", 
                "description": "The control diet will be a conventional food diet aiming to provide 800 to 1000 kcal/day. It will be prescribed by the dietitian at the Imperial Weight Centre.", 
                "intervention_name": "Control diet", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "morbid obesity", 
            "gastric bypass", 
            "bariatrics", 
            "diet", 
            "caloric restriction", 
            "liver fat", 
            "appetite"
        ], 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom", 
                    "state": "greater London", 
                    "zip": "W12 0NN"
                }, 
                "name": "Imperial Clinical research facility"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Effect of a 2-week vs. 6-week Low-calorie Diet (LCD) Followed by Roux-en-Y Gastric Bypass (RYGB) on Body Composition and Surgery Outcomes in Obese Humans: a Dietary Intervention and Magnetic Resonance Imaging Study", 
        "other_outcome": [
            {
                "measure": "Change in peptide tyrosine tyrosine (PYY) concentrations following the pre-operative diet", 
                "safety_issue": "No", 
                "time_frame": "at 2 weeks or 6 weeks depending on the group"
            }, 
            {
                "measure": "Change in peptide tyrosine tyrosine (PYY) concentrations following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 1 month following Roux-en-Y gastric bypass"
            }, 
            {
                "measure": "Change in peptide tyrosine tyrosine (PYY) concentrations following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 6 months following Roux-en-Y gastric bypass"
            }, 
            {
                "measure": "Change in Glucagon-like peptide-1 (GLP-1) concentrations following the pre-operative diet", 
                "safety_issue": "No", 
                "time_frame": "at 2 weeks or 6 weeks depending on the group"
            }, 
            {
                "measure": "Change in Glucagon-like peptide-1 (GLP-1) concentrations following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 1 month following Roux-en-Y gastric bypass"
            }, 
            {
                "measure": "Change in Glucagon-like peptide-1 (GLP-1) concentrations following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 6 months following Roux-en-Y gastric bypass"
            }
        ], 
        "overall_official": {
            "affiliation": "Imperial College London", 
            "last_name": "Prof Gary S Frost, RD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Intra-hepatocellular lipid content will be measured by magnetic resonance spectroscopy", 
            "measure": "Change in Intra-hepatocellular lipid content (IHCL) following the pre-operative diet", 
            "safety_issue": "No", 
            "time_frame": "at 2 weeks or 6 weeks depending on group"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02144597"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Intra-hepatocellular lipid content (IHCL) will be compared between groups at 1 month following Roux-en-Y gastric bypass", 
                "measure": "Change in Intra-hepatocellular lipid content (IHCL) following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 1-month following Roux-en-Y gastric bypass"
            }, 
            {
                "measure": "Change in glucose levels following the pre-operative diet", 
                "safety_issue": "No", 
                "time_frame": "at 2 weeks or 6 weeks depending on the group"
            }, 
            {
                "description": "Intra-hepatocellular lipid content (IHCL) will be compared between groups at 6 months following Roux-en-Y gastric bypass", 
                "measure": "Change in Intra-hepatocellular lipid content (IHCL) following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 6 months following Roux-en-Y gastric bypass"
            }, 
            {
                "measure": "Change in glucose levels following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 1 month following Roux-en-Y gastric bypass"
            }, 
            {
                "measure": "Change in glucose levels", 
                "safety_issue": "No", 
                "time_frame": "at 6 months following Roux-en-Y gastric bypass"
            }, 
            {
                "measure": "Change in insulin levels following the pre-operative diet", 
                "safety_issue": "No", 
                "time_frame": "at 2 weeks or 6 weeks depending on the group"
            }, 
            {
                "measure": "Change in insulin levels following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 1 month following Roux-en-Y gastric bypass"
            }, 
            {
                "measure": "Change in insulin levels following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 6 months following Roux-en-Y gastric bypass"
            }, 
            {
                "description": "Body composition will be measured by magnetic resonance imaging. The volume of different fat compartments will be assessed by an independent company blinded to the dietary intervention group.", 
                "measure": "Change in body composition following the pre-operative diet", 
                "safety_issue": "No", 
                "time_frame": "at 2 weeks or 6 weeks depending on the group"
            }, 
            {
                "description": "Body composition will be measured by magnetic resonance imaging. The volume of different fat compartments will be assessed by an independent company blinded to the dietary intervention group.", 
                "measure": "Change in body composition following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 1 month following Roux-en-Y gastric bypass"
            }, 
            {
                "description": "Body composition will be measured by magnetic resonance imaging. The volume of different fat compartments will be assessed by an independent company blinded to the dietary intervention group.", 
                "measure": "Change in body composition following Roux-en-Y gastric bypass", 
                "safety_issue": "No", 
                "time_frame": "at 6 months following Roux-en-Y gastric bypass"
            }, 
            {
                "description": "Complexity of surgery will be assessed by the surgeon at the time of surgery", 
                "measure": "complexity of surgery", 
                "safety_issue": "No", 
                "time_frame": "at the time of surgery"
            }, 
            {
                "description": "The operative time will be recorded at the time of surgery by the operating surgeon", 
                "measure": "operative time", 
                "safety_issue": "No", 
                "time_frame": "at the time of surgery"
            }
        ], 
        "source": "Imperial College London", 
        "sponsors": {
            "collaborator": {
                "agency": "Cambridge Manufacturing Company Limited", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Imperial College London", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}